NDC 81033-003-40 - Diphenhydramine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-003
- Requested NDC
- 81033-003-40
- Package NDCs from labels
- 81033-003-05, 81033-003-50, 81033-003-52, 81033-003-10, 81033-003-40, 81033-003-41
- Manufacturer
- Kesin Pharma Corporation
- Effective date
- 2023-01-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diphenhydramine Hydrochloride - Kesin Pharma Corporation | Kesin Pharma Corporation | 2023-01-16 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81033-003-41 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-189d-a2ce-e063-dadaa90aadf7 | Diphenhydramine HCl 2.5mg/mL Unit Dose Cups, 12.5mg/5 mL, 25mg/10mL |
| 81033-003-52 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-189d-a2ce-e063-dadaa90aadf7 | Diphenhydramine HCl 2.5mg/mL Unit Dose Cups, 12.5mg/5 mL, 25mg/10mL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-003-05 | Diphenhydramine Hydrochloride | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 2 | |
| 81033-003-10 | Diphenhydramine Hydrochloride | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 2 | |
| 81033-003-40 | Diphenhydramine Hydrochloride | 40 in 1 CARTON | LIQUID | 40 | 2 | |
| 81033-003-41 | Diphenhydramine Hydrochloride | 8 in 1 CASE | LIQUID | 8 | 2 | |
| 81033-003-50 | Diphenhydramine Hydrochloride | 50 in 1 CARTON | LIQUID | 50 | 2 | |
| 81033-003-52 | Diphenhydramine Hydrochloride | 8 in 1 CASE | LIQUID | 8 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-003-05 | ML - Milliliter | 81033-003 | f3701be5-9a5c-438f-b934-93806d66ebd4 | 1 | 2021-10-08 |
| 81033-003-10 | ML - Milliliter | 81033-003 | 5d902f8f-3bc7-4bea-914d-2933d9172d09 | 1 | 2021-10-08 |
| 81033-003-40 | ML - Milliliter | 81033-003 | 7ba3f437-e501-4726-9cbd-0f7dde860113 | 1 | 2021-10-08 |
| 81033-003-50 | ML - Milliliter | 81033-003 | 29f4b183-8acf-4b5d-9c82-ef7967038684 | 1 | 2021-10-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lemon | GLYCERIN | Sion Biotext Medical Ltd | dbd7ed86-1b92-4471-827a-89f3afa1b0dc | 2026-01-08 | Warnings | PDC6A3C0OX |
| Glycerin Combination 9304 | GLYCERIN COMBINATION | Professional Complementary Health Formulas | 391d8517-9b89-4b62-97b5-5102b35bec46 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Libido Stim Liquescence 3014 | LIBIDO STIM LIQUESCENCE | Professional Complementary Health Formulas | 3d59b77d-817b-4021-a6dd-75d3b4b60866 | 2026-01-08 | Warnings | PDC6A3C0OX |
| DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED | AMZ789 LLC | 12dd2419-b2e0-5466-e063-6394a90a4221 | 2026-01-07 | Warnings | TC2D6JAD40 |
| DIPHENHYDRAMINE HYDROCHLORIDE 50mg | DIPHENHYDRAMINE HYDROCHLORIDE 50MG | AMZ789 LLC | af0b1b08-e269-6399-e053-2a95a90ac12d | 2026-01-07 | Warnings | TC2D6JAD40 |
| Complete Allergy Medicine | DIPHENHYDRAMINE HCL | Salado Sales, Inc. | c0f5c8ca-b187-40bf-9245-6a29f1c32c97 | 2026-01-06 | Warnings | TC2D6JAD40 |
| Goodmeds Extra Strength Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Cabinet Health P.B.C. | 02c60967-46d7-49b7-82be-bc3c5fd36484 | 2026-01-06 | Warnings | TC2D6JAD40 |
| Proctozone-G | GLYCERIN | Rising Pharma Holdings, Inc. | 8a5c8ad5-3619-4971-967d-165270a20bc8 | 2026-01-06 | Warnings | PDC6A3C0OX |
| Proctozone GMax | GLYCERIN | Rising Pharma Holdings, Inc. | a13c2be6-d650-4b53-bddd-d55e92fe10c6 | 2026-01-06 | Warnings | PDC6A3C0OX |
| Good Sense Hemorrhoidal Maximum Strength Pain Relief | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | L. Perrigo Company | 1d6142b6-3746-46f1-99ec-4b19d26f056e | 2026-01-06 | Warnings | PDC6A3C0OX |
| Sting Relief prep Pad | STING RELIEF PREP PAD | SHENZHEN BENLIJU BIO-TECH CO.,LTD | 202c7b77-1a48-52a5-e063-6394a90a2eb2 | 2026-01-05 | Warnings | PDC6A3C0OX |
| Skin Cleaning Care Wipes | SKIN CLEANING CARE WIPES | SHENZHEN BENLIJU BIO-TECH CO.,LTD | 203d7a95-65fe-ca65-e063-6294a90acc6e | 2026-01-05 | Warnings | PDC6A3C0OX |
| Diphenhydramine HCl | DIPHENHYDRAMINE HCL | NuCare Pharmaceuticals,Inc. | 3c323dc8-f734-b44c-e063-6394a90a6184 | 2026-01-05 | Warnings | TC2D6JAD40 |
| Pain Relief Acetaminophen PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Rite Aid Corporation | f77f0120-4042-4b11-ba9c-cd35e1cd0bee | 2026-01-05 | Warnings | TC2D6JAD40 |
| CVS Maximum OTC Strength Hemorrhoidal with Aloe | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY,INC | b55c63fb-5dfa-4567-8192-58f403868837 | 2026-01-02 | Warnings | PDC6A3C0OX |
| Eye Clean | EYE WASH | HART Health | 41f53e2e-c2bc-4bf1-a541-3bcb2cf63002 | 2025-12-31 | Warnings | 059QF0KO0R |
| Colirio Ojo De Aguila Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Grandall Distributing Co., Inc. | 31aa07e9-0cc9-2a77-e063-6394a90a4b9d | 2025-12-31 | Warnings | PDC6A3C0OX |
| GeriCare Sorbitol Solution | SORBITOL | GERI-CARE PHARMACEUTICALS, CORP | b4dd7a41-380e-d94b-e053-2a95a90ac34a | 2025-12-31 | Warnings | 506T60A25R |
| Itch Relief | DIPHENHYDRAMINE HCL | FSA Store Inc. | 47434af6-0fdd-9615-e063-6394a90ab9e8 | 2025-12-31 | Warnings | TC2D6JAD40 |
| Puregen Labs Allergy Relief | DIPHENHYDRAMINE HCL | Advanced Rx LLC | 4745d4f9-bbdf-a4a6-e063-6294a90a15b2 | 2025-12-31 | Warnings | 1049906 TC2D6JAD40 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.